CERo Therapeutics is selling for under 0.0154 as of the 18th of January 2025; that is 9.22 percent increase since the beginning of the trading day. The stock's lowest day price was 0.0148. CERo Therapeutics has more than 66 % chance of experiencing financial distress in the next few years of operation. However, it had a very good returns during the last 90 days.CERo Therapeutics symbol was changed from PBAXW on 15th of February 2024. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 18th of January 2025. Click here to learn more.
CERo Therapeutics Holdings (CEROW) is traded on NASDAQ Exchange in USA. It is located in 201 Haskins Way, South San Francisco, CA, United States, 94080 and employs 8 people. CERo Therapeutics Holdings was previously known as PBAXW Old and was traded on NASDAQ Exchange under the symbol PBAXW. CERo Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification. The company classifies itself under Healthcare sector and is part of Biotechnology industry.
CERo Therapeutics generates negative cash flow from operations
Check CERo Therapeutics Probability Of Bankruptcy
CERo Therapeutics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. CERo Therapeutics market risk premium is the additional return an investor will receive from holding CERo Therapeutics long position in a well-diversified portfolio.
Elected by the shareholders, the CERo Therapeutics' board of directors comprises two types of representatives: CERo Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CERo. The board's role is to monitor CERo Therapeutics' management team and ensure that shareholders' interests are well served. CERo Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CERo Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
When running CERo Therapeutics' price analysis, check to measure CERo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CERo Therapeutics is operating at the current time. Most of CERo Therapeutics' value examination focuses on studying past and present price action to predict the probability of CERo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CERo Therapeutics' price. Additionally, you may evaluate how the addition of CERo Therapeutics to your portfolios can decrease your overall portfolio volatility.